tiprankstipranks
Hangzhou Tigermed Consulting Co., Ltd. Class H (HK:3347)
:3347
Hong Kong Market

Hangzhou Tigermed Consulting Co., Ltd. Class H (3347) Financial Statements

Compare
1 Followers

Hangzhou Tigermed Consulting Co., Ltd. Class H Financial Overview

Hangzhou Tigermed Consulting Co., Ltd. Class H's market cap is currently HK$44.07B. The company's EPS TTM is HK$1.198; its P/E ratio is 27.63; and it has a dividend yield of 1.90%. Hangzhou Tigermed Consulting Co., Ltd. Class H is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is HK$-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue¥ 7.38B¥ 7.09B¥ 5.21B¥ 3.19B¥ 2.80B
Gross Profit¥ 2.85B¥ 2.81B¥ 2.27B¥ 1.51B¥ 1.30B
Operating Income¥ 2.49B¥ 2.58B¥ 1.92B¥ 1.12B¥ 1.08B
EBITDA¥ 2.91B¥ 2.42B¥ 2.11B¥ 1.27B¥ 1.17B
Net Income¥ 2.02B¥ 2.01B¥ 2.87B¥ 1.75B¥ 841.63M
Balance Sheet
Cash & Short-Term Investments¥ 7.46B¥ 7.88B¥ 8.57B¥ 10.15B¥ 2.04B
Total Assets¥ 29.68B¥ 27.45B¥ 23.74B¥ 19.51B¥ 7.53B
Total Debt¥ 2.83B¥ 2.80B¥ 1.19B¥ 384.94M¥ 1.05B
Net Debt¥ -4.59B¥ -5.06B¥ -7.35B¥ -9.74B¥ -990.92M
Total Liabilities¥ 5.23B¥ 4.77B¥ 3.14B¥ 1.65B¥ 2.01B
Stockholders' Equity¥ 21.03B¥ 19.58B¥ 18.12B¥ 16.12B¥ 4.23B
Cash Flow
Free Cash Flow¥ 836.68M¥ 908.90M¥ 1.06B¥ 842.18M¥ 424.65M
Operating Cash Flow¥ 1.15B¥ 1.36B¥ 1.42B¥ 998.68M¥ 527.56M
Investing Cash Flow¥ -1.53B----
Financing Cash Flow¥ -7.81M¥ 809.25M-¥ 9.34B¥ 1.43B
Currency in CNY

Hangzhou Tigermed Consulting Co., Ltd. Class H Earnings and Revenue History

Hangzhou Tigermed Consulting Co., Ltd. Class H Debt to Assets

Hangzhou Tigermed Consulting Co., Ltd. Class H Cash Flow

Hangzhou Tigermed Consulting Co., Ltd. Class H Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis